Mirum Pharmaceuticals
World Rank (Aug-2026)
3,000
Market Cap (Aug-2026)
6.535 Billion USD
World Rank (Jan-05-2024)
7,121
Market Cap (Jan-05-2024)
1.384 Billion USD
World Rank (Jul-30-2023)
8,800
Market Cap (Jul-30-2023)
0.988 Billion USD
World Rank (Dec-25-2022)
10,559
Market Cap (Dec-25-2022)
0.673 Billion USD
World Rank (Jan-07-2022)
13,731
Market Cap (Jan-07-2022)
0.48 Billion USD
Annual Revenue in USD
521 Million USD
Annual Net Income in USD
-23 Million USD
Annual Results for Period Ending
For year ending December-2025
Company Profile
Mirum Pharmaceuticals is a Clinical Stage Biopharmaceutical company focused on clinical studies for the treatment of cholestatic diseases including primary sclerosing cholangitis (PSC), intrahepatic cholestasis of pregnancy (ICP) and primary biliary cholangitis (PBC). It is having 24 employees as on 2019. The headquarters is in USA.
Company Website